Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MORNING BID-Asking for more stimulus?

Wed, 08th Jul 2020 09:04

* A look at the day ahead from EMEA deputy markets editor
Sujata
Rao. The views expressed are her own

LONDON, July 8 (Reuters) - Share markets are wavering after
snapping a five-day winning streak on Tuesday when world stocks
tumbled 1% and all three U.S. indexes closed in the red.

This morning, Wall Street futures and European equities are
both lower, Treasury yields are close to the one-week lows they
plumbed on Tuesday and German yields are 2 basis points lower.
China's Shanghai and Shenzhen benchmarks continued to march
higher in what's widely seen as a state-sanctioned rally.

In keeping with the jittery mood, the dollar is holding firm
as is gold. The Chinese rally has stoked demand for commodities,
pushing Shanghai copper to its highest in more than a year.
Chinese equity gains – the seventh day in a row – also pushed
emerging equities 0.7% higher.

The most obvious explanation for the pullback is the rise in
U.S. coronavirus cases, with 3 million confirmed cases and
localised activity restrictions. Atlanta Fed President Rafael
Bostic said there was a real sense the coronavirus crisis "might
go on longer than we have planned for".

Criticism of U.S President Donald Trump's handling of the
crisis is seen damaging his re-election chances, forcing Wall
Street to contend with the possibility of a Democrat
administration, higher taxes and tighter regulation.

Markets may also be hankering after another dose of stimulus
– Fed Vice Chair Richard Clarida said there was no limit to how
much bond buying the Fed could do.

The Cleveland Fed's Loretta Mester, meanwhile, called for
more help from the fiscal side. She may have hit the nail on the
head -- there's some unease as the scheme to supplement U.S.
jobless payments expires at the end of July just as the COVID-19
spike threatens to derail new hiring.

Consultancy Oxford Economics points out the worsening
coronavirus comes just as liquidity provision from central banks
and governments is slowing – central banks' balance-sheet growth
isn't accelerating any more, while some governments seem wary of
further fiscal measures that risk adding to debt.

Barclays said this morning in its annual equity-gilt study
that while all the extra borrowing is needed, deficits will need
to be addressed some day, with higher taxes part of the
solution.

Speaking of fiscal stimulus, British finance minister Rishi
Sunak is expected to announce measures to counter the jump in
unemployment. Aside from spending 3 billion pounds to improve
energy efficiency, he could announce VAT cuts, lower property
purchases taxes and vouchers to aid hospitality businesses. The
pound is holding near three-week highs before his speech.

In European corporate news, AstraZeneca and Merck &
Co said their cancer treatment Lynparza won European
Union approval for treating a form of pancreatic cancer.

Shares in Traton were down 3.6% after the company
announced management changes. Deutsche Post
was up 1.3% after reporting a 16% rise in
second-quarter operating profit.

In coronavirus-linked bad news, logistics company DHL may
cut as many as 2000 UK jobs, the Unite trade union said;
FirstGroup warned on its ability to continue as a going
concern, after posting an annual operating loss and plunging
passenger volumes; OMV second-quarter output dropped
5% in wake of coronavirus pandemic.

In emerging markets, China's yuan is near 7 to the dollar
after briefly breaking through the threshold on Tuesday.
Nigeria' naira fell 5.5% on Tuesday following central bank FX
sales at a lower rate -- possibly after pressure from lenders
and markets to unify its plethora of exchange rates.

Non-deliverable forwards see the naira losing a fifth of its
value over the next 12 months.
(Editing by Larry King
)

More News
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.